What is Abequolixron used for?

Abequolixron is being studied as a potential treatment for non-small cell lung carcinoma, endometrial cancer, and other types of tumors.

Is Abequolixron approved for use?

No, Abequolixron is currently in the early stages of clinical research (Phase 1) and is not yet an approved medication.

What kind of drug is Abequolixron?

Abequolixron is classified as a small molecule compound.

What stage of testing is Abequolixron in?

It is currently in Phase 1 of clinical trials.

Can Abequolixron treat lung cancer?

Research is looking into whether Abequolixron can be used for non-small cell lung carcinoma.

Can Abequolixron treat endometrial cancer?

Abequolixron is being investigated for its potential use in treating endometrial cancer.

Abequolixron | CAS 610318-54-2 | ZLJZDYOBXVOTSA

Loading compound...

Small molecule cancer research compound

Abequolixron is a small molecule drug currently being studied in early-stage clinical research. It is being investigated for its potential to treat certain types of cancer, including non-small cell lung carcinoma and endometrial cancer.

How it worksThe drug is a small molecule being studied for its ability to target specific biological processes related to tumor growth in various cancers.

Used for

Non-small cell lung carcinomaEndometrial cancerGeneral neoplasms (tumors)

Conditions

Non-small cell lung carcinomaEndometrial cancerNeoplasms

Class

Small moleculeSmall molecule cancer research compound

How to take

Abequolixron is currently in Phase 1 clinical trials, meaning its safety and specific dosing are still being determined in humans.

Talk to your doctor

Questions to ask

·Is Abequolixron part of any clinical trials I might qualify for?
·How does Abequolixron differ from my current cancer treatment?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)